← Back to the disclosure log

Who in Congress Has Traded Bristol-Myers Squibb Company (BMY)?

The Bristol-Myers Squibb Company line shows up 136 times in the congressional disclosure record between 2013 and 2026, filed by 37 members: 78 purchases against 58 sales. On balance the chamber has been net buyers, and the purchases sit up 28.6% against the latest close.

136Trades
78Buys
58Sells
37Members
$66.82Latest close 2026-10-26
+28.6%Congress buys vs latest close*

*Purchases only, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings report a range, never a share count, so this follows the stock rather than anyone's position size.

57% buys43% sells

How it splits by party

Republicans
47 buys · 44 sells
23 members · 91 trades
Democrats
31 buys · 13 sells
13 members · 44 trades

Whose BMY buys have done best

Members ranked by how their reported BMY purchases have moved since, over roughly the last three years, weighted by disclosed band midpoint and marked to the latest close.

1 Rohit Khanna
+31.9%
2 Alan Armstrong
+14.1%
3 Virginia Foxx
+12.5%
DateMemberTypeAmountEst. priceLatest closeReturn
2026-05-07Mike KellySELL$15K–$50K$56.25$66.82 2026-09-04-18.8% exit
2026-03-27Alan ArmstrongBUY$1K–$15K$58.54$66.82 2026-09-04+14.1%
2025-06-24Virginia FoxxSELL$1K–$15K$47.03$66.82 2026-09-04-42.1% exit
2025-05-19Rohit KhannaSELL$1K–$15K$47.22$66.82 2026-09-04-41.5% exit
2025-04-15Thomas H TubervilleSELL$1K–$15K$50.00$66.82 2026-09-04-33.6% exit
2025-04-15Thomas H TubervilleSELL$1K–$15K$50.00$66.82 2026-09-04-33.6% exit
2024-12-06Virginia FoxxBUY$1K–$15K$59.38$66.82 2026-09-04+12.5%
2024-04-03Thomas H TubervilleSELL$1K–$15K$52.18$66.82 2026-09-04-28.1% exit
2024-04-03Thomas H TubervilleBUY$1K–$15K———
2024-01-10Rohit KhannaBUY$50K–$100K$50.66$66.82 2026-09-04+31.9%
2024-01-09Rick LarsenSELL$1K–$15K$51.28$66.82 2026-09-04-30.3% exit
2024-01-03Thomas H TubervilleSELL$1K–$15K$52.30$66.82 2026-09-04-27.8% exit
2023-11-16Thomas H TubervilleSELL$1K–$15K——— exit
2023-10-17Thomas H TubervilleBUY$1K–$15K$57.37$66.82 2026-09-04+16.5%
2023-08-22Daniel S SullivanSELL$1K–$15K$61.86$66.82 2026-09-04-8.0% exit
2023-08-22Daniel S SullivanSELL$1K–$15K$61.86$66.82 2026-09-04-8.0% exit
2023-07-28Rohit KhannaSELL$1K–$15K$61.41$66.82 2026-09-04-8.8% exit
2023-05-10Shelley M CapitoSELL$1K–$15K$68.49$66.82 2026-09-04+2.4% exit
2023-04-25Rohit KhannaBUY$1K–$15K$70.24$66.82 2026-09-04-4.9%
2023-01-10Daniel S SullivanSELL$1K–$15K$71.65$66.82 2026-09-04+6.7% exit
2022-11-28Nicholas V. TaylorSELL$100K–$250K$79.14$66.82 2026-09-04+15.6% exit
2022-11-08Kurt SchraderBUY$1K–$15K$79.98$66.82 2026-09-04-16.4%
2022-06-17Shelley M CapitoSELL$1K–$15K$73.77$66.82 2026-09-04+9.4% exit
2022-01-18Thomas R CarperBUY$1K–$15K$64.89$66.82 2026-09-04+3.0%
2021-11-29Thomas R CarperBUY$1K–$15K$54.64$66.82 2026-09-04+22.3%
2021-11-10Carol Devine MillerSELL$15K–$50K$59.39$66.82 2026-09-04-12.5% exit
2021-10-28Kim Dr SchrierSELL$1K–$15K$57.13$66.82 2026-09-04-17.0% exit
2021-09-23John A. YarmuthBUY$1K–$15K$60.63$66.82 2026-09-04+10.2%
2021-09-22John A. YarmuthBUY$1K–$15K$60.15$66.82 2026-09-04+11.1%
2020-12-30Thomas R CarperBUY$1K–$15K$61.92$66.82 2026-09-04+7.9%
2020-11-25Rick LarsenBUY$1K–$15K$62.84$66.82 2026-09-04+6.3%
2020-07-21John RutherfordBUY$1K–$15K$59.80$66.82 2026-09-04+11.7%
2020-06-21John RutherfordBUY$1K–$15K$56.41$66.82 2026-09-04+18.4%
2020-04-16David A Perdue , JrSELL$1K–$15K$59.56$66.82 2026-09-04-12.2% exit
2020-04-16David A Perdue , JrSELL$1K–$15K$59.56$66.82 2026-09-04-12.2% exit
2020-04-14David A Perdue , JrSELL$15K–$50K$60.04$66.82 2026-09-04-11.3% exit
2020-04-14David A Perdue , JrSELL$15K–$50K$60.04$66.82 2026-09-04-11.3% exit
2020-04-14Kelly LoefflerSELL$250K–$500K$60.04$66.82 2026-09-04-11.3% exit
2020-04-14Kelly LoefflerSELL$100K–$250K$60.04$66.82 2026-09-04-11.3% exit
2020-04-03Katherine M. ClarkBUY$1K–$15K$55.53$66.82 2026-09-04+20.3%
2020-03-13Nicholas Van TaylorSELL$100K–$250K$54.99$66.82 2026-09-04-21.5% exit
2020-03-04George HoldingBUY$1K–$15K$61.48$66.82 2026-09-04+8.7%
2020-01-21Mikie SherrillBUY$1K–$15K$67.43$66.82 2026-09-04-0.9%
2019-12-18Mikie SherrillSELL$1K–$15K$63.15$66.82 2026-09-04-5.8% exit
2019-11-26Gilbert CisnerosSELL$1K–$15K$56.73$66.82 2026-09-04-17.8% exit
2019-08-15David A Perdue , JrSELL$15K–$50K$45.75$66.82 2026-09-04-46.0% exit
2019-07-25Mikie SherrillBUY$1K–$15K$45.40$66.82 2026-09-04+47.2%
2019-07-15David A Perdue , JrBUY$15K–$50K$44.19$66.82 2026-09-04+51.2%
2019-07-10John RutherfordSELL$1K–$15K$45.96$66.82 2026-09-04-45.4% exit
2019-05-28Rohit KhannaBUY$1K–$15K$45.86$66.82 2026-09-04+45.7%

Buys are marked to the latest close and treated as open. A sell tagged rt closes an earlier disclosed buy in the same name. exit shows how the stock moved after the member sold.

Next →

Frequently asked — Bristol-Myers Squibb Company (BMY) congressional trades

Which lawmakers have traded Bristol-Myers Squibb Company (BMY)?

37 members of the U.S. House and Senate have disclosed Bristol-Myers Squibb Company transactions under the STOCK Act — 78 purchases and 58 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.

Which lawmakers bought BMY recently?

No member of Congress has disclosed a BMY purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.

How have Congress's BMY trades performed?

Notional-weighted, lawmakers' disclosed BMY buys are up 28.6% versus the latest close of $66.82. Each trade's own return — and realized round-trips on matched sells — is in the Return column.

Is it legal for members of Congress to trade Bristol-Myers Squibb Company?

Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded BMY and how it performed.

Related stocks — also traded by the same lawmakers

MSFT 32AAPL 27JNJ 26AMZN 25PFE 25CSCO 25XOM 24DIS 24CVS 24CVX 24T 23MRK 23GE 22WFC 22GOOGL 22PG 22PEP 22CMCSA 22